William Chase on Abbott's M&A strategy - The Deal Pipeline (SAMPLE CONTENT: NEED AN ID?)
Subscriber Content Preview | Request a free trialSearch  
  Go

Video

Share  |  Reprint

William Chase on Abbott's M&A strategy

Published November 19, 2012 at 1:04 PM


William Chase, Abbott Laboratories' vice president of licensing and acquisitions, and The Deal Pipeline's Ben Fidler discuss the pharmaceutical giant's acquisition strategy as it prepares to split into two different companies at the start of 2013. - George White

Share:

Meet the journalists



Movers & Shakers

Launch Movers and shakers slideshow

Carmelo Anthony, who just signed a $122 million contract with the New York Knicks, and former NBC executive Stuart Goldfarb co-founded Melo7 Tech Partners LLC. For other updates launch today's Movers & shakers slideshow.

Video

Rockland Capital to take bids for New Jersey plant

Teasers on Eagle Point went out to prospective buyers in May and the facility, formerly owned by Sunoco, will probably fetch about $240 million. More video

Sectors